ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
North Terrace House,
19 North Terrace,
Hackney, SA, 5069
1300 128 339
Closed over Christmas
(reopened 1 February 2017)
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
The Institute for Advanced Medical Research launches Fibromyalgia study
Thursday 23 October 2014
The Institute for Advanced Medical Research Launches Fibromyalgia Study
Alpharetta facility offers support for those with fibromyalgia
ALPHARETTA, Ga. -- Oct. 21, 2014 -- PRZen -- Today the Institute for Advanced Medical Research announced that they will launch a new clinical trial for fibromyalgia on November 1, 2014. The pivotal phase 3 trial will test the efficacy of a new compound.
Fibromyalgia (FM) can best be described as a chronic pain state caused by excitation of nerves carrying pain signals to the brain. It is a highly complex disorder with a variety of symptoms that come and go, making it difficult to identify, diagnose and treat. The disease also includes specific pain trigger points useful in making a clear diagnosis. Experts predict that approximately 10 million Americans have this disorder, most of them women.
In addition to the chronic, debilitating pain of fibromyalgia, many of the symptoms of fibromyalgia are similar to other medical conditions and actually often co-exists with others including severe fatigue, insomnia, muscle knots, cramping and weakness, brain fog and IBS.
“Currently, there are only three drugs approved for treating fibromyalgia and much needs to be done in the area of research. There is no cure for fibromyalgia and today treatment is focused on the management of the chronic pain; because of the chronic pain issues, many people with fibromyalgia become withdrawn from family and friends and even become depressed,” offered Angelo Sambunaris, M.D., Founder and President of the Institute. “This study provides an in-depth diagnostic evaluation and support from an expert at no cost to the participant, providing benefits for both the individual and the advancement of medicine.”
To learn more or schedule an evaluation, please call 770-817-9200, or visit IAMResearch.org.
About the Institute for Advanced Medical Research
The Institute for Advanced Medical Research empowers individuals struggling with neuropsychological conditions to actively participate in their treatment. By educating and informing patients and their families, the team offers them a renewed sense of purpose. Rather than simply being victims of a disease, study participants become health care heroes, creating a personal legacy of advancing medical science.
Adhering to the highest standards of quality and strict ethical principles of medical research, the Institute employs a patient-centered approach that balances a commitment to safety with highly personalized care. Since 1991, the Institute has helped more than 3,000 individuals improve their quality of life while ensuring that millions more can benefit from access to innovative medical treatments. For more information, visit the Institute for Advanced Medical Research website at IAMResearch.org, or call 770-817-9200.
Source: The Institute for Advanced Medical Research
The above originally appeared here.
blog comments powered by Disqus